scispace - formally typeset
S

Stephen P. Staal

Researcher at National Institutes of Health

Publications -  11
Citations -  1372

Stephen P. Staal is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Virus & Murine leukemia virus. The author has an hindex of 8, co-authored 9 publications receiving 1332 citations.

Papers
More filters
Journal ArticleDOI

Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.

TL;DR: The results demonstrate that AKT8 has the characteristic structure of a directly transforming retrovirus and that it contains a gene derived from highly conserved cellular sequences that may be involved in the pathogenesis of some human malignancies.
Journal ArticleDOI

Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma

TL;DR: Murine leukemia viruses capable of malignant transformation of mink tissue culture cells have been isolated from an AKR thymoma cell line and from a spontaneous reticulum cell sarcoma in an NIH Swiss mouse partially congenic for the AKR ecotropic virus-inducing locus Akv-2.
Journal ArticleDOI

Identification of ecotropic proviral sequences in inbred mouse strains with a cloned subgenomic DNA fragment.

TL;DR: A specific probe for detecting ecotropic murine leukemia virus sequences was constructed by cloning a 500-base-pair DNA segment, corresponding to a portion of the env region of the AKR ecotropic virus, in a pBR322/Escherichia coli K-12 host/vector system.
Journal ArticleDOI

Human T-cell leukemia-lymphoma virus (HTLV): cloning of an integrated defective provirus and flanking cellular sequences.

TL;DR: The results indicate that the infected cells are of clonal origin with respect to the virus integration sites and they express multiple viral mRNA species including a 35S RNA.
Journal ArticleDOI

Effect of interferon on murine leukemia virus infection. II. Synthesis of viral components in exogenous infection.

TL;DR: It is confirmed that interferon inhibits later steps of MuLV replication; the block occurs after transcription of viral mRNA and synthesis of virus-specific gs antigens and the major viral glycoprotein.